Mediwhale
Mediwhale has recently raised $13 million in Series C funding, which will also support its entry into the United States market.
Also, Mediwhale raised $12 million for its United States expansion.
Also, Seegene will be leveraging Microsoft's AI to advance the development of syndromic quantitative PCR diagnostic tests globally.